Ryan Norbury, Ian Grant, Alex Woodhead, Stephen D Patterson
{"title":"Acute hypoalgesic and neurophysiological responses to lower-limb ischaemic preconditioning.","authors":"Ryan Norbury, Ian Grant, Alex Woodhead, Stephen D Patterson","doi":"10.1007/s00221-024-06985-7","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to assess if ischaemic preconditioning (IPC) can reduce pain perception and enhance corticospinal excitability during voluntary contractions. In a randomised, within-subject design, healthy participants took part in three experimental visits after a familiarisation session. Measures of pressure pain threshold (PPT), maximum voluntary isometric force, voluntary activation, resting twitch force, corticospinal excitability and corticospinal inhibition were performed before and ≥10 min after either, unilateral IPC on the right leg (3 × 5 min); a sham protocol (3 × 1 min); or a control (no occlusion). Pain perception was then assessed in response to a hypertonic saline injection into the vastus lateralis muscle. In the right (occluded) leg, PPT was 10% greater after IPC compared to sham (P = 0.004). PPTs were also 9.5% greater in the contralateral leg for IPC compared to sham (P = 0.031). Maximum voluntary force, voluntary activation and resting twitch force were not different between conditions (all P ≥ 0.133). Measures of corticospinal excitability and inhibition also revealed no significant differences between conditions (all P ≥ 0.240). Hypertonic saline evoked pain revealed no difference in reported intensity or duration between conditions (P ≥ 0.082). IPC can reduce pain sensitivity in local and remote areas but does not subsequently impact neurophysiological measures of excitability or inhibition.</p>","PeriodicalId":12268,"journal":{"name":"Experimental Brain Research","volume":"243 1","pages":"41"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Brain Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00221-024-06985-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The aim of this study was to assess if ischaemic preconditioning (IPC) can reduce pain perception and enhance corticospinal excitability during voluntary contractions. In a randomised, within-subject design, healthy participants took part in three experimental visits after a familiarisation session. Measures of pressure pain threshold (PPT), maximum voluntary isometric force, voluntary activation, resting twitch force, corticospinal excitability and corticospinal inhibition were performed before and ≥10 min after either, unilateral IPC on the right leg (3 × 5 min); a sham protocol (3 × 1 min); or a control (no occlusion). Pain perception was then assessed in response to a hypertonic saline injection into the vastus lateralis muscle. In the right (occluded) leg, PPT was 10% greater after IPC compared to sham (P = 0.004). PPTs were also 9.5% greater in the contralateral leg for IPC compared to sham (P = 0.031). Maximum voluntary force, voluntary activation and resting twitch force were not different between conditions (all P ≥ 0.133). Measures of corticospinal excitability and inhibition also revealed no significant differences between conditions (all P ≥ 0.240). Hypertonic saline evoked pain revealed no difference in reported intensity or duration between conditions (P ≥ 0.082). IPC can reduce pain sensitivity in local and remote areas but does not subsequently impact neurophysiological measures of excitability or inhibition.
期刊介绍:
Founded in 1966, Experimental Brain Research publishes original contributions on many aspects of experimental research of the central and peripheral nervous system. The focus is on molecular, physiology, behavior, neurochemistry, developmental, cellular and molecular neurobiology, and experimental pathology relevant to general problems of cerebral function. The journal publishes original papers, reviews, and mini-reviews.